Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome-Reference-Cited by-同舟云学术

Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome

Published:2001-10 Issue:5 Volume:3 Page:601-610
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Capomolla Soccorso¹,Febo Oreste¹,Opasich Cristina²,Guazzotti Giampaolo¹,Caporotondi Angelo¹,La Rovere Maria Teresa¹,Gnemmi Marco¹,Mortara Andrea³,Vona Margherita¹,Pinna Gian Domenico¹,Maestri Roberto¹,Cobelli Franco¹

Affiliation:

1. Fondazione S. Maugeri, Clinica del Lavoro e della Riabilitazione; IRCCS Istituto scientifico di Montescano; Pavia Italy

2. Istituto scientifico di Pavia; Pavia Italy

3. Policlinico di Monza; Milano Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Heart failure in the: evolution of a major public health problem in cardiovascular medicine;Garg;J Am Coll Cardiol,1993

2. Heart failure disease management: a critical review;Rich;J Heart Failure,1998

3. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure;Packer;N Eng J Med,1996

4. Optimizing therapy for complex or refractory heart failure: a management algorithm;Stevenson;Am Heart J,1998

5. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy;Carrol;Circulation,1986

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium nitroprusside infusion in patients with advanced heart failure;Vascular Pharmacology;2024-09

2. Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis;Journal of Cardiovascular Pharmacology;2024-07

3. Hydralazine combined with conventional therapy improved outcomes in severe systolic dysfunction and mitral regurgitation;ESC Heart Failure;2023-10-27

4. Sodium nitroprusside for advanced heart failure. A metanalysis of literature data;Vascular Pharmacology;2023-02

5. PRO: vasodilators remain an indispensable treatment for acute heart failure;European Heart Journal. Acute Cardiovascular Care;2022-10-08